Various mGluRs have been implicated in multiple neurodegenerative diseases (e.g., AD, HD, and PD) but mGluR5 is the most well-studied, offering potential as a therapeutic target and diagnostic tool [10]. Here, GRM5 is linked to Parkinson disease.